Interferon-λ Genetic Variations and Hepatitis C: Yet to be Discovered

authors:

avatar Maryam Keshvari 1 , 2 , avatar Heidar Sharafi 2 , *

Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, IR Iran
Middle East Liver Diseases (MELD) Center, Tehran, IR Iran

how to cite: Keshvari M, Sharafi H. Interferon-λ Genetic Variations and Hepatitis C: Yet to be Discovered. Hepat Mon. 2014;14(5):e19433. https://doi.org/10.5812/hepatmon.19433.

References

  • 1.

    Tipu I, Marriage F, Farooqi ZU, Platt H, Athar MA, Day PJ, et al. The IFN-lambda Genetic Polymorphism Association With the Viral Clearance Induced by Hepatitis C Virus Treatment in Pakistani Patients. Hepat Mon. 2014;14(3). ee15076. [PubMed ID: 24734091]. https://doi.org/10.5812/hepatmon.15076.

  • 2.

    Sarrazin C, Susser S, Doehring A, Lange CM, Muller T, Schlecker C, et al. Importance of IL28B gene polymorphisms in hepatitis C virus genotype 2 and 3 infected patients. J Hepatol. 2011;54(3):415-21. [PubMed ID: 21112657]. https://doi.org/10.1016/j.jhep.2010.07.041.

  • 3.

    Moghaddam A, Melum E, Reinton N, Ring-Larsen H, Verbaan H, Bjoro K, et al. IL28B genetic variation and treatment response in patients with hepatitis C virus genotype 3 infection. Hepatology. 2011;53(3):746-54. [PubMed ID: 21374656]. https://doi.org/10.1002/hep.24154.

  • 4.

    Prokunina-Olsson L, Muchmore B, Tang W, Pfeiffer RM, Park H, Dickensheets H, et al. A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus. Nat Genet. 2013;45(2):164-71. [PubMed ID: 23291588]. https://doi.org/10.1038/ng.2521.

  • 5.

    Honda M, Sakai A, Yamashita T, Nakamoto Y, Mizukoshi E, Sakai Y, et al. Hepatic ISG expression is associated with genetic variation in interleukin 28B and the outcome of IFN therapy for chronic hepatitis C. Gastroenterology. 2010;139(2):499-509. [PubMed ID: 20434452]. https://doi.org/10.1053/j.gastro.2010.04.049.

  • 6.

    Raglow Z, Thoma-Perry C, Gilroy R, Wan YJ. IL28B genotype and the expression of ISGs in normal liver. Liver Int. 2013;33(7):991-8. [PubMed ID: 23522062]. https://doi.org/10.1111/liv.12148.

  • 7.

    Abe H, Hayes CN, Ochi H, Maekawa T, Tsuge M, Miki D, et al. IL28 variation affects expression of interferon stimulated genes and peg-interferon and ribavirin therapy. J Hepatol. 2011;54(6):1094-101. [PubMed ID: 21145800]. https://doi.org/10.1016/j.jhep.2010.09.019.

  • 8.

    Suppiah V, Moldovan M, Ahlenstiel G, Berg T, Weltman M, Abate ML, et al. IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy. Nat Genet. 2009;41(10):1100-4. [PubMed ID: 19749758]. https://doi.org/10.1038/ng.447.

  • 9.

    Tanaka Y, Nishida N, Sugiyama M, Kurosaki M, Matsuura K, Sakamoto N, et al. Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C. Nat Genet. 2009;41(10):1105-9. [PubMed ID: 19749757]. https://doi.org/10.1038/ng.449.